Bachmann G, Lobo RA, Gut R, Nachtigall L, Notelovitz M. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial. Obstet Gynecol 2008;111:67 ...

Please provide your email address to receive an email when new articles are posted on . Researchers identified no link between vaginal estrogen tablet use and recurrent stroke risk. The findings did ...

A total of 3353 recurrent cases were identified from a cohort of 56,642 women with a first-time stroke and were matched with 3353 controls. HealthDay News — For women with a history of ischemic stroke ...

BAUDETTE, Minn., Sept. 12, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that it received U.S. Food and Drug Administration (FDA) approval for ...

Hormone replacement therapy using vaginal estrogen tablets was not associated with an increased risk of ischemic stroke for postmenopausal women who have already had a stroke, according to a data ...

In Danish women with a history of ischemic stroke, use of vaginal estradiol tablets was not associated with an increased rate of recurrent ischemic stroke. Results suggest these women may not be so ...

Demand for estrogen patches surged 26% after the FDA removed a black box warning on hormone therapy in 2025 ...

The health sector sees significant developments with C4 Therapeutics and Roche forming a billion-dollar cancer drug deal, AG1 ...

Women deserve high-quality care. The best evidence supports taking hormone therapy in menopause because it’s the most ...

Exposure to vaginal estradiol not linked to increased rate of recurrent ischemic stroke when adjusted for comorbidity, medications, income, education. (HealthDay News) — For women with a history of ...

Researchers saw no link between vaginal estrogen therapy and recurrent strokes, despite concerns that the hormone is systemically absorbed. In a case-control study of female stroke survivors across ...